Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A 60-year-old woman with recurrent episodes of flushing, urticaria, and angioedema.

Literature DB >> 25976440

A 60-year-old woman with recurrent episodes of flushing, urticaria, and angioedema.

Abstract

Recurrent episodes of flushing, urticaria, and angioedema raise suspicion for many conditions with a wide differential diagnosis. The diagnostic approach involves consideration of allergic, cardiovascular, gastrointestinal, endocrine, infectious, neurologic, dermatologic, and drug-related causes. We describe a unique case of recurrent episodes of flushing, urticaria, and angioedema that has gone into remission after a novel therapeutic intervention.

Entities: Disease Species

Mesh：

Year: 2015 PMID： 25976440 PMCID： PMC4405605 DOI： 10.2500/aap.2015.36.3836

Source DB: PubMed Journal: Allergy Asthma Proc ISSN： 1088-5412 Impact factor: 2.587

11 in total

1. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors: Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal: Int Arch Allergy Immunol Date: 2011-10-27 Impact factor: 2.749

Review 2. Mast cell activation syndrome: a review.

Authors: Marianne Frieri; Reenal Patel; Jocelyn Celestin
Journal: Curr Allergy Asthma Rep Date: 2013-02 Impact factor: 4.806

3. Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study.

Authors: Andy Rorie; Whitney S Goldner; Elizabeth Lyden; Jill A Poole
Journal: Ann Allergy Asthma Immunol Date: 2014-02-05 Impact factor: 6.347

4. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations.

Authors: Matthew J Hamilton; Jason L Hornick; Cem Akin; Mariana C Castells; Norton J Greenberger
Journal: J Allergy Clin Immunol Date: 2011-05-28 Impact factor: 10.793

5. Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects.

Authors: Gerhard J Molderings; Kirsten Meis; Ulrich W Kolck; Jürgen Homann; Thomas Frieling
Journal: Immunogenetics Date: 2010-09-14 Impact factor: 2.846

6. Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypothesis.

Authors: Raymond James Mullins; Sunday Clark; Carlos A Camargo
Journal: Ann Allergy Asthma Immunol Date: 2009-12 Impact factor: 6.347

7. Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.

Authors: Kwok-Ho Yip; Natasha Kolesnikoff; Chunping Yu; Nicholas Hauschild; Houng Taing; Lisa Biggs; David Goltzman; Philip A Gregory; Paul H Anderson; Michael S Samuel; Stephen J Galli; Angel F Lopez; Michele A Grimbaldeston
Journal: J Allergy Clin Immunol Date: 2014-01-22 Impact factor: 10.793

A 60-year-old woman with recurrent episodes of flushing, urticaria, and angioedema.

1. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Review 2. Mast cell activation syndrome: a review.

3. Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study.

4. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations.

5. Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects.

6. Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypothesis.

7. Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.

Review 8. Mast cell activation syndromes: definition and classification.

9. Bone marrow biopsies for the diagnosis of systemic mastocytosis: is one biopsy sufficient?

Review 10. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.

1. Disorders for which the allergist-immunologist is particularly well-qualified to treat.